Company: NGVT
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001653477-25-000091
Chunk: 18

Company: Ingevity Corp
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---
 $— $— $3.8 Liabilities:Deferred compensation arrangement (4)$15.3 $— $— $15.3 Total liabilities$15.3 $— $— $15.3 In millionsLevel 1(1)Level 2(2)Level 3(3)TotalDecember 31, 2024Assets:Deferred compensation plan investments (4)$3.7 $— $— $3.7 Total assets$3.7 $— $— $3.7 Liabilities:Deferred compensation arrangement (4)$15.9 $— $— $15.9 Total liabilities$15.9 $— $— $15.9 ______________(1) Quoted prices in active markets for identical assets.(2) Quoted prices for similar assets and liabilities in active markets.(3) Significant unobservable inputs.(4) Consists of a deferred compensation arrangement through which we hold various investment securities recognized on our condensed consolidated balance sheets. Both the asset and liability related to investment securities are recorded at fair value and are included within "Other assets" and "Other liabilities" on the condensed consolidated balance sheets, respectively. In addition to the investment securities, we also had company-owned life insurance related to the deferred compensation arrangement recorded at cash surrender value in "Other assets" of $16.3 million and $16.5 million at March 31, 2025 and December 31, 2024, respectively.

9

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsMarch 31, 2025(Unaudited)

Nonrecurring Fair Value MeasurementsThere were no nonrecurring fair value measurements on the condensed consolidated balance sheets during the periods ended March 31, 2025, and December 31, 2024. Strategic InvestmentsEquity Method InvestmentsThe aggregate carrying value of all strategic equity method investments totaled $15.3 million and $15.4 million at March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025, we had approximately $5.2 million of unfunded commitments, associated with a venture capital fund investment accounted for under the equity method of accounting. We anticipate this will be paid over a period of 10 years, beginning from the fourth quarter of 2022. There were no adjustments to the carrying value of equity method